# Meloxicam

## Mobicam 15mg

| 藥物代碼           | OMOBI                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Painful osteoarthritis, rheumatoid arthritis, ankylosing spondylitis.                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 副作用             | Dyspepsia, nausea, vomiting, abdominal pain, constipation, flatulence, diarrhoea, anaemia, pruritus, rash, lightheadedness, headache, oedema.Cardiovascular: Edema (0.6% to 4.5% )Gastrointestinal: Abdominal pain (1.9% to 4.7% ), Constipation (0.8% to 2.6% ), Diarrhea (1.9% to 7.8% ), Flatulence (3.2% ), Indigestion (3.8% to 9.5% ), Nausea (2.4% to 7.2% ), VomitingNeurologic: Dizziness (1.1% to 3.8% ), Headache (2.4% to 8.3% )Respiratory: Upper respiratory infection (up to 8.3% )Other: Fever |
| 禁忌               | Hypersensitivity to NSAIDs or aspirin. Active peptic ulceration, severe hepatic insufficiency, non-dialysed severe renal insufficiency. Children < 15 years. Pregnancy & lactation.                                                                                                                                                                                                                                                                                                                            |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 用法用量           | Osteoarthritis 7.5 mg/day. May be increased to 15 mg/day. RA 15 mg/day. May be reduced to 7.5 mg/day. Ankylosing spondylitis 15 mg/day. Max: 15 mg/day.                                                                                                                                                                                                                                                                                                                                                        |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 懷孕用藥危分級     | 儘量避免                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 孕期用藥建議       | Human data suggest risk in 1st and 3rd trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 附帶說明           | [20201124非類固醇消炎藥品安全資訊風險溝通表] 懷孕20週以上孕婦使用NSAIDs可能會導致胎兒腎功能障礙並導致羊水過少； 妊娠30週以上之孕婦可能導致胎兒動脈導管過早閉合的風險。                                                                                                                                                                                                                                                                                                                                         |
| 哺乳期用藥建議     | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |

